Table II.
Clinical information of cirrhotic patients in the survival and death groups (6 months following blood sample collection).
| Parameter | Survival (n=77) | Death (n=24) | P-value |
|---|---|---|---|
| Age, years | 63±12 | 68±10 | 0.070 |
| Sex, M/F | 51/27 | 17/6 | 0.614 |
| Etiology | |||
| Viral, n (%) | 40 (51.9) | 11 (45.8) | 0.601 |
| Alcoholic, n (%) | 15 (19.5) | 4 (16.7) | 0.993 |
| Autoimmune, n (%) | 8 (10.4) | 3 (12.5) | 0.720 |
| Others, n (%) | 14 (18.2) | 6 (25.0) | 0.558 |
| ALT, U/l | 21±16 | 25±23 | 0.916 |
| ALP, U/l | 95±38 | 129±55 | 0.001 |
| Albumin, g/l | 34±8 | 28±5 | 0.002 |
| PT, sec | 14.6±2.6 | 16.6±4.3 | 0.012 |
| MELD | 12.34±4.73 | 17.19±5.32 | <0.001 |
ALT, alanine transaminase; ALP, alkaline phosphatase; F, female; M, male; PT, prothrombin time; MELD, model for end-stage liver disease.